Cytokine-stimulated human osteosarcoma cells (MG-63) secrete several related chemotactic factors, including the neutrophil-activating protein interleukin 8 (IL-8) and the monocyte chemotactic protein (MCP)-I. We describe the isolation and characterization of two novel monocyte chemotactic factors from this tumor cell line. Although these proteins copurified with MCP-1 and Ib8 on heparin-Sepharose, they could be separated by cation-exchange fast protein liquid chromatography and reverse-phase high-performance liquid chromatography. The corresponding 7.5-and 11-kD proteins were NH2-terminally blocked but were identified by sequencing peptide fragments. They showed a primary structure mostly related to that of MCP-1 and were therefore designated MCpo2 and MCP-3, respectively. These molecules can be dassified in a subfamily of proinfhmmatory proteins characterized by the conservation of cysteine residues. MCP-2 and MCP-3 are also functionally related to MCP-1 because they specifically attract monocytes, but not neutrophils, in vitro. The chemotactic potency (specific activity) was comparable for all three MCPs. Intradermal injection of these proteins in rabbits resulted in selective monocyte recruitment in vivo. Since tumor cells are good producers of leukocyte chemotactic factors, it could be questioned whether these molecules can indirectly control tumor growth by attracting leukocytes or whether they rather promote invasion by the secretion of proteases from the attracted cells.
C
ell migration is an important phenomenon in inflammation and in the invasive behavior of tumors. In response to infection, phagocytes are attracted to the inflammatory focus through the generation of chemotactic gradients. Recently, chemotactic factors belonging to a novel family of proinflammatory proteins have been identified (1) (2) (3) (4) (5) (6) (7) . In contrast to the classical chemoattractants (e.g., C5a, FMLP), these molecules specifically affect the migration of single types of leukocytes. Within this family of structurally related, low relative molecular mass factors, II.-8 is a well-characterized neutrophil-activating protein (1) (2) (3) (4) (5) . Ib-8 can be grouped into a class (designated CXC chemokines) based upon the position of the two NH2-terminal, conserved cysteines. Monocyte chemotactic protein 1 (MCP-1) 1 belongs to a second class (CC chemokines), in which these cysteines are adjacent (6, 7) . MCP-1 is an attractant for monocytes but not for neutrophils (6) (7) (8) . Except for some platelet products, these inflammatory proteins can be induced in various cell types (fibroblasts, endothelial cells, monocytes, lymphocytes) in response 1 Abbreviations used in this paper: CPG, controlled pore glass; GCP, granulocyte chemotactic protein; MCP, monocyte chemotactic protein.
to a variety of stimuli, including cytokines (1) (2) (3) (4) (5) (6) (7) (8) . Several transformed ceil types have also been described to secrete these chemotactic factors. This implies that chemoattractants might play a role in tumor biology (9) . We describe here the identification of two novel monocyte chemotactic factors isolated from stimulated osteosarcoma cells. Since the proteins were found to be biochemicaUy and biologically related to MCP-1, they are designated MCP-2 and MCP-3.
Materials and Methods

Production and Purification of Monocyte Chemotactic Activity,
Human MG-63 osteosarcoma cells (8, 10) were stimulated with pure human IblB or semi-purified cytokine derived from mitogenstimulated mononuclear cells. After 5 h of induction, cell cultures were washed and incubated with serum-free or serum-containing (2% FCS) growth medium for 48 h at 37~ MCP (3 liters/batch) was concentrated and partially purified by adsorption to controlled pore glass (CPG-10-350; Serva, Heidelberg, Germany). The CPG eluate was further purified by antibody affinity chromatography using a polyclonal antibody to fibroblast-derived cytokine (11) . Alternatively, MCP was purified by heparin-Sepharose (CL-6B; Pharmacia, Uppsala, Sweden) chromatography. MCP was eluted in a linear NaC1 gradient (0.05-2 M) in 50 mM Tris, pH 7.4 (8) . MCP recovered by antibody or heparin-Sepharose chromatography was further purified by Mono S FPLC (Pharmacia) in 50 mM formate, pH 4.0. After an extensive wash with equilibration buffer, activity was eluted (1 ml/min) in a linear NaC1 gradient (0-1 M) in 50 mM formate, pH 4.0.
Fractions were checked for purity by SDS/PAGE. Samples (3-20 /~1) were loaded onto a linear gradient (10-25%) polyacrylamide gel, and silver stained (8, 11) . The relative molecular mass markers (Bio-Rad Laboratories, Richmond, CA) used were phosphorylase b (Mr 92,500), BSA (Mr 66,200), OVA (Mr 45,000), carbonic anhydrase (Mr 31,000), soybean trypsin inhibitor (Mr 21,500), lysozyme (Mr 14,400), and the low relative molecular mass marker (Pierce Chemical Co., Rockford, IL) aprotinin (M, 6,500).
Identification of Monocyte Chemotactic Proteins by Sequence Analysis.
MCPs were purified to homogeneity by reverse-phase HPLC (8) . Active fractions from FPLC were analyzed on a 220 x 2.1-mm C-8 Aquapore P,.P-300 column (Applied Biosystems, Inc., Foster City, CA) equilibrated with 0.1% TFA. Chemotactic activity was eluted with an acetonitrile gradient in 0.1% TFA at 0.4 ml/min.
Tryptic fragments from 4/~g MCP were prepared by digestion with 0.2/~g bovine trypsin (sequencing grade; Boehringer Mannhelm, Mannheim, Germany) for 18 h at 37~ (8) . Alternatively, 4/~g of MCP was digested by addition of 0.2/~g of endoproteinase Asp-N, asparaginylendopeptidase, or endoproteinase Lys-C (sequencing grade; Boehringer Mannheim) at 37~ for 18 h. The MCP fragments obtained were separated by reverse-phase HPLC, as described for the final purification of MCP. Amino acid sequences of proteins and peptides were determined in duplicate with an online sequencing in duplicate with an on-line sequencing system (477A/120A; Applied Biosystems, Inc.). Cysteine residues were confirmed after on falter reduction with tributylfosfine and modification with 4-vinylpyridine.
Assays.for Cheraotaxis and Activation of Cells. PBMC were isolated by hydroxyethyl starch sedimentation and FicoU-sodium metrizoate centrifugation (8) . Neutrophils were further purified by hypotonic shock and Percoll gradient centrifugation (8) .
Chemotaxis under agarose was measured according to the method of Ndson et al. (12) and as previously described (8, 13) . The titration end-point, corresponding to I U/ml, was calculated from a dilution resulting in the half-maximal effective migration distance as compared with that obtained with human granulocyte chemotactic protein (GCP)/IL-8 (13) or MCP-1 (8) .
Migration of monocytes and granulocytes was also assessed by the microchamber (Neuro Probe Inc., Cabin John, MD) technique (8, 14) . An optimal concentration of purified human MCP-1 (8) or GCP/IL-8 (13) was used as a reference chemoattractant. The chemotactic index was calculated from the number of cells migrated to the test sample divided by the number of cells migrated to the control medium.
Release of gelatinase B was used as a parameter to measure monocyte or granulocyte activation. Purified granulocytes (5 x 106 cells/ml) or adherent monocytes (2 h/37~ were stimulated (in serum-free medium) with test reagents for 45 min or 18 h, respectively. Supernatants were centrifuged to remove cells, and gelatinase activity was determined by SDS/PAGE zymography (15) .
In Vivo Infiltration of Leukoq/tes in Rabbit Skin. New Zealand white rabbits were shaved at the abdomen and injected intraderreally with the indicated doses of homogeneous, pyrogen-free MCP preparations (100/xlAite, eight sites/rabbit). After 18 h, rabbits were killed and the injection sites were excised. Skin biopsies were processed for routine histology, stained with hematoxylin-eosin, and microscopically examined.
Results
Isolation and Identification of Human MCP-2 and MCP-3.
The monocTte chemotactic activity from stimulated MG-63 cells was concentrated by adsorption to CPG beads and further purified by antibody affinity chromatography or heparinSepharose chromatography. Distinct monocyte chemotactic activities could subsequently be separated by cation-exchange FPLC (Fig. 1) . The predominant activity eluted at 0.5 M NaC1 in the gradient and corresponded to two major protein bands (10 and 16 kD) previously identified as MCP-lo~ and MCP-1B (6, 8) . In addition, a second and a third MCP peak were recovered at 0.7 and 0.6 M NaC1, and were designated MCP-2 and MCP-3, respectively (Fig. 1) .
To investigate the nature of these additional MCP peaks from FPLC, their activities were purified to homogeneity (in parallel with MCP-1) by reverse-phase HPLC. Fig. 2 A shows that MCP-1 eluted on HPLC at m26% acetonitrile, whereas MCP-2 and MCP-3 eluted at 30% and 27.5% acetonitrile, respectively. This further indicated that the latter activities represent distinct factors. Homogeneous MCP-1 remained heterogenous upon SDS-PAGE in that multiple molecular mass bands (10, 12, 14 , and 16 kD) were eluting in single HPLC fractions (Fig. 2 B) . Sequence analysis revealed that all these MCP-1 proteins were NH2-terminally blocked. Identity with authentic MCP-1 was confirmed by sequencing fragments (from residues 3-26 and 54-60 of the mature protein) of an Asp-N endoproteinase digest (Fig. 3) .
MCP-2 and MCP-3 were found to reside in a 7.5-and 11-kD protein, respectively (Fig. 2 B) . MCP-2 and MCP-3 also had a blocked NH2-terminus, but could be identified through fragmentation of (twice) 4/~g pure MCP-2 and MCP-3 with trypsin or Asp-N endoproteinase and (once) 4/~g MCP-3 with asparaginyl-or Lys-C endoproteinase. Sequence analysis of the obtained fragments, separated by HPLC, demonstrated that both MCP-2 and MCP-3 have a primary struc- ture related to, but distinct from, MCP-1 (Fig. 3) . The alignment of multiple overlapping sequence fragments allowed for the identification of nearly the complete primary structure of MCP-2 and about 90% of that of MCP-3. MCP-2 and MCP-3 showed 62.5% and 73% identity with MCP-1, respectively. A search in the EMBL/Swiss-Prot Band (PC/ Gene release, February 1992) did not provide evidence for identity of the sequences with any known protein structure. However, a profound literature search revealed that the MCP-2 sequence is identical to the cDNA-derived sequence of HC14, an IFN-7-inducible gene in monocytes (16) . The cDNA sequence of HC14 has not yet been disclosed and the corresponding protein has not been expressed to permit biological characterization.
Biological Characterization of MCP-2 and MCP-3 In Vitro and In Vivo. In the assay measuring migration under agarose, MCP-2 and MCP-3 showed specific activities (1 U corresponding to a half-maximal migration distance) of ~10 4 U/rag, comparable with that of MCP-1. In contrast, at the highest dose tested, no neutrophil chemotactic activity could be detected with all three MCP species (<103 U/mg), whereas Ib8 had a specific activity of 10 s U/mg for neutrophils. Fig. 4 compares the chemotactic potency (minimum effective concentration) and efficacy (maximal effect at optimal concentration) of MCP-1, MCP-2, and MCP-3 in the microchamber migration assay. All three MCPs are most efficacious for monocyte chemotaxis at 1 nM, the effect of MCP-3 being somewhat lower. The minimum effective concentration was 0.1-0.3 nM. The spedfic activity (1 U corresponding to a stimulation index of 2.5) in this monocyte microchamber assay was calculated to be 7 x 105, 4 x 10 s, and 4 x 105 U/mg for MCP-1, MCP-2, and MCP-3, respectively. In contrast, their specific activity for neutrophils was found to be < 5 x 104 U/rag, whereas IL-8 scored >2 x 106 U/mg.
It was verified whether MCP-1, -2, and -3 could activate monocytes to secrete gelatinase B. Although by their adherence monocytes can spontaneously secrete gelatinase activity, the production of the 85-kD enzyme could be enhanced by treatment with either MCP-1, -2, or -3 (data not shown).
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In contrast, on neutrophils no gelatinase B release was observed with any of the MCP molecules, whereas these cells were found to release this enzyme after treatment with
I1,8 (15).
Finally, the three factors were compared for their chemotactic potency after administration in vivo (Fig. 5) . Purified, endotoxin-free material was therefore injected intradermally into rabbit skin (10-500 ng/site). A selective and prominent infiltration of monocytes was noticed with MCP-1, -2, and -3. At 10 ng/site, MCP-2 and MCP-3 were still able to elicit an intradermal monocyte recruitment. The appropriate control (pyrogen-free saline) did not influence leukocyte infiltration. The monocyte infiltration was characterized by clustering of cells, visible monocyte adherence to endothelia (margination), and accumulation of monocytes around the site of injection (Fig. 5) .
Discussion
This study describes the identification of two novel monocyte chemotactic factors isolated from human tumor cells. Since the corresponding 7.5-and 11-kD proteins show high structural and functional similarity with MCP-1 (8, 17, 18) , they are designated MCP-2 and MCP-3, respectively. Based on the conservation of four cysteine residues, these'molecules can be classified in a family of small proinflammatory proteins (1) (2) (3) (4) (5) (6) (7) (8) . In accordance with most members of this chemokine family, MCP-2 and MCP-3 show affinity for heparin.
Almost the complete primary structure of MCP-2 (95 %) could be disclosed by sequencing fragments of the NHzterminally blocked mature protein. Out of 72 residues determined, 45 (62.5%) were found to be identical to those in MCP-1. Although the MCP-2 sequence was not contained in the EMBL/Swiss-Prot Bank, the primary structure of this chemotactic factor fully corresponded to that of the cDNAderived sequence of leukocyte-derived HC14. The HC14 gene encodes a protein of 99 amino acids, including a signal peptide of 23 residues (16) . The primary structure of the mature MCP-3 protein, a third chemotactic factor for monocytes, was almost completely determined. From the fragments (67 residues) sequenced, it can be deduced that MCP-3 is more closely related to human MCP-1 (73% similarity) than to MCP-2 (60% similarity).
All three MCPs possess similar specific activities in monocyte chemotaxis assays. Concordantly with MCP-1, MCP-2 and -3 are selective attractants because no significant effect could be observed on neutrophils. The specific activity of MCPs for neutrophil chemotaxis is at least 50-fold lower than that of II.-8. The effect on other cell types (e.g., lymphocytes) needs to be investigated in more detail.
MCP-1 and II.-8 exert chemotactic activity in vivo in that they cause both locally and systematically a recruitment of monocytes and neutrophils, respectively (13, 19) . Similarly, MCP-2 and MCP-3 were found to induce monocyte infiltration after intradermal injection in rabbit skin. Occasionally, few neutrophils (<5% of total leukocyte counts) were also noticed in the skin section. It was also consistently observed that the monocytes occurred in "clusters" or "nests" at the injection site, and marginating cells were sometimes seen in contact with the endothelial lining of the venules. This effect seemed most pronounced with MCP-3.
Murine macrophage inflammatory protein 1 (20) and other human molecules of this subfamily, such as RANTES (7), have been reported to possess monocyte chemotactic activity. However, the structural similarity of these proteins with MCP-1 is weaker than that of MCP-2 and -3. Since MCPs isolated from other species, such as the mouse (21) and the rat (22) , show comparable sequence homology with the three human MCPs, it cannot be concluded whether these proteins actually represent the homologue of human MCP-1. In contrast, rabbit (23) and bovine (24) MCPs are structurally more related to human MCP-1 and MCP-3 than to MCP-2.
Unless the tumor cells were stimulated, none of these low molecular mass proteins, including MCP-I, -2, and -3, could be recovered by purification from cell supernatants. If cells were treated for 48 h with semi-purified leukocyte-derived cell supernatants (containing IL-1, II,6, IFN-% and possibly other cytokines), secretion of MCP-3 and MCP-1 was rather consistent, whereas that of MCP-2 remained variable. IFN-3' has been reported to be a major inducer of HC14/MCP-2 mRNA in monocytes (16) . Induction of MCP-3 was observed in MG-63 cells stimulated with pure II-13 under serum-free Figure 5 . Infiltration of monocytes in rabbit skin after intradermal injection with human MCPs. Different doses of MCP-1, -2, and -3, (50 and 500 ngAite) in 100 gl pyrogenfree physiological saline (0.9% NaC1, used as control) were injected. Shown are representative histological sections of the skin biopsies at 18 h after injection (x 300). MCP-3 (500 ng/site) at x300 is magnified from the frame at x 75 (/eft, bottom). This x 75 magnification clearly shows the injection site and the frame was drawn at the border of the intradermal papula.
conditions (not shown). Addition of 2% FCS further increased the production level, indicating that the regulation of MCP secretion is complex. The possibility that MCP-3 could represent the bovine equivalent of MCP-1 (copurified from the serum additive) was excluded since both MCPs were produced under serum-free conditions or in the presence of human serum. As a control, MCP was isolated from bovine kidney cells and was found to possess a protein sequence distinct from that of the human MCPs (data not shown). Furthermore, isolation of a bovine MCP from seminal plasma (24) revealed a primary structure still different from that of bovine kidney cell-derived MCP. The molecular cloning of the MCP-2 and MCP-3 genes will enable a detailed study of the expression in various cell systems.
Tumor cells seem to be good producers of chemotactic factors. It could therefore be questioned whether the MCPs identified here play a role in the control of tumor cell growth and invasion. Indeed, tumor-derived monocyte chemotactic activity is reportedly correlated with the presence of tumorassociated macrophages (9) . MCP-activated monocytes might thus be important in tumor immune surveillance by inhibiting cell growth (19) . Alternatively, we speculate that chemotactic substances might promote invasion and metastasis by protease secretion from the attracted and activated leukocytes.
In conclusion, the structural and functional identification of two novel MCPs extends the growing list of molecules belonging to this superfamily ofproinflammatory cytokines.
Since both new chemokines are equally active in vitro and in vivo when compared with MCP-1, the question remains why nature provides several of these closely related chemotactic factors. It therefore remains essential to investigate whether some of these have still other unrelated biological functions or whether some could serve as antagonist of MCP or II.-8, for instance, through competition for receptor binding.
